A Study to Evaluate Food Effect on ONO-5920/YM529 Intermittent Formulation

Clinical trial NCT00965978 · COMPLETED

Trial details

NCT number: NCT00965978
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Osteoporosis Osteoporosis, Postmenopausal Bone Diseases

Start date: 2009-07-01
Primary completion: 2009-09-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.